- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05601297
Acceptability of Women to Intimate Partner Violence and Its Correlates Among Attendants of Maternal and Child Center in Assiut
Acceptability of Women to Intimate Partner Violence and Its Correlates Among Attendants of Maternal and Child Health Center in Assiut City
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Violence against women is a major public health problem . World Health Organization estimates that globally 30% of women have been subjected to either physical and/or sexual intimate partner violence(IPV) or non-partner sexual violence in their lifetime.
IPV refers to any behaviour within an intimate relationship that causes physical, psychological or sexual harm to those in the relationship. IPV definition covers violence by both current and former spouses and partners. Forms of intimate partner violence include: Acts of physical violence, sexual violence, emotional (psychological) abuse, and controlling behaviors.
Initial studies on IPV against women tended to concentrate on assessment of incidence and prevalence. Although prevalence is critical, reducing or eliminating some problems also requires comprehension of cultural norms and expectations.
An ecological approach showed that public attitudes accepting or justifying violence and aggression are a risk factor at a macro social level, as they can encourage or deter its occurrence in societies.
UN Women reported that among Egyptian women in reproductive age, the prevalence of lifetime physical and/or sexual intimate partner violence was 26% and the prevalence of physical and/or sexual intimate partner violence in the last 12 months was 14 %.
The Egyptian studies that assessed attitudes of acceptability of IPV and their predictors has explored acceptability to only one form of IPV. Using a single-item measures, they measured justification for the husband's use of more severe physical force in response to the wife's violation of expected domestic roles or his patriarchal control in marriage.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Hagar Ahmed, physician
- Phone Number: 01098494064
- Email: physicianHagar123@gmail.com
Study Contact Backup
- Name: Eman Morsi, professor
- Phone Number: 01006261140
- Email: emanmma@yahoo.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Data will be collected through a semi-structured interviewer administered questionnaire Interviewer administered questionnaire
- Personal and demographic characters of women and their husbands; age, religion, current residence and residence in childhood (urban and rural), education, employment.
- Family characteristics: family type nuclear or extended, if the couples are blood relatives or not, media exposure, and assessment of family socioeconomic status using family income in L.E per month, response to the absence of economic difficulty in making it to the end of the month (much difficulty, difficulty, certain difficulty, much ease, ease, or certain ease)(10), and the Egypt socioeconomic scale by El-Gilany A (11).
Description
Inclusion Criteria:
- Ever married women (current married women and who were married since one year) who seek health services at MCH center.
Exclusion Criteria:
- single women not previously married
- and women who were married since more than one year
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
level of acceptability of intimate partner violence among ever married women
Time Frame: 2 years
|
Acceptability to IVP will be measured using the A-IPVAW scale is a 20-item measure assessing attitudes of acceptability or tolerance of IPVAW (e.g., "It is acceptable for a man to shout at his partner if she is continuously arguing and nagging him, to hit his partner if she is constantly nagging/arguing, to push his partner into having sex because he spent money on her , to threaten to leave his partner in order to achieve something he wants, not to allow his partner to work or study, to prevent his partner from seeing family and friends, to control his partner's mobile phone").
The response format of these items is a 3-point Likert-type scale (i.e., 0 = "Not acceptable," 1 = "Somewhat acceptable," 2 = "Acceptable").
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
level of victim blaming attitude in case of intimate partner violence
Time Frame: 2 years
|
Victim-blaming attitudes in Cases of Intimate Partner Violence will be assessed using a short version of (VB-IPVAW).
It composes of 12 items e.g.( men are violent towards their partners because they make them jealous, men are violent towards their partners because women provoke them, men are violent towards their partners because women need to be controlled, men are violent towards their partners because women are not patient enough with them, men would change their violent behavior towards their partners if they were more obedient, women could avoid violence from their malepartners if they knew when to stop talking).
Respondents will be asked to indicate their level of agreement with the item statements on a 4-point Likert-type scale (1 = strongly disagree, 2= somewhat disagree, 3= somewhat agree, 4 = strongly agree).
|
2 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- partner violance against women
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Violence Against Women
-
Chulalongkorn UniversityAsia and Oceania Federation of Obstetrics and GynaecologyNot yet recruitingViolence Against Women
-
Macmillan Research Group UKSonal Foundation, India; Goldington Family Center, UK; Vinita Nursing Home, IndiaUnknownViolence Against WomenIndia, United States, Australia, China, Greece, Pakistan, South Africa
-
Chulalongkorn UniversityAsia and Oceania Federation of Obstetrics and GynaecologyNot yet recruitingViolence Against Women
-
Econometría ConsultoresInter-American Development BankCompletedViolence Against Women (VAW)Colombia
-
Econometría ConsultoresInter-American Development BankSuspendedViolence Against Women (VAW)Colombia
-
McMaster UniversityEcho: Improving Women's Health in Ontario (formerly Ontario Women's Health...CompletedIntimate Partner Violence Against WomenCanada
-
Haramaya UnversityUniversity of Ghana; World Health OrganizationUnknownDomestic Violence Against Women | Community-based Prevention | Interevntion ImplementationEthiopia
-
International Centre for Diarrhoeal Disease Research...Population Council; Marie Stopes International; Bangladesh Legal Aid and Services... and other collaboratorsCompletedSexual and Reproductive Health and Rights | Violence Against Women and Girls
-
Econometría ConsultoresInter-American Development BankCompletedViolence Against Women (VAW)Colombia
-
London School of Hygiene and Tropical MedicineInternational Rescue Committee; National Institutes of Medical Research, Tanzania and other collaboratorsUnknownChild Abuse | Violence | Violence, Physical | Violence Against Children